Alpha Tau Medical Ltd., (DRTS): Price and Financial Metrics
DRTS Price/Volume Stats
| Current price | $2.75 | 52-week high | $4.39 |
| Prev. close | $2.60 | 52-week low | $1.75 |
| Day low | $2.67 | Volume | 14,139 |
| Day high | $2.88 | Avg. volume | 100,410 |
| 50-day MA | $3.21 | Dividend yield | N/A |
| 200-day MA | $2.60 | Market Cap | 192.29M |
DRTS Stock Price Chart Interactive Chart >
Alpha Tau Medical Ltd., (DRTS) Company Bio
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
DRTS Price Returns
| 1-mo | -10.71% |
| 3-mo | -11.29% |
| 6-mo | 15.79% |
| 1-year | -9.54% |
| 3-year | -72.75% |
| 5-year | N/A |
| YTD | -11.29% |
| 2024 | 2.99% |
| 2023 | -5.35% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...